LifeStance Health Group, Inc.
LFST
$3.89
-$0.01-0.26%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 332.97M | 325.48M | 312.72M | 312.33M | 300.44M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 332.97M | 325.48M | 312.72M | 312.33M | 300.44M |
| Cost of Revenue | 223.18M | 216.04M | 212.29M | 214.53M | 205.71M |
| Gross Profit | 109.79M | 109.44M | 100.43M | 97.81M | 94.73M |
| SG&A Expenses | 94.43M | 93.23M | 84.91M | 94.85M | 88.18M |
| Depreciation & Amortization | 13.76M | 14.67M | 15.12M | 18.60M | 22.56M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 331.37M | 323.94M | 312.32M | 327.97M | 316.46M |
| Operating Income | 1.60M | 1.54M | 405.00K | -15.64M | -16.02M |
| Income Before Tax | -1.47M | -8.88M | -5.38M | -22.62M | -20.73M |
| Income Tax Expenses | -2.18M | -1.76M | 575.00K | 656.00K | 363.00K |
| Earnings from Continuing Operations | 709.00K | -7.11M | -5.96M | -23.28M | -21.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 709.00K | -7.11M | -5.96M | -23.28M | -21.10M |
| EBIT | 1.60M | 1.54M | 405.00K | -15.64M | -16.02M |
| EBITDA | 15.36M | 16.21M | 15.52M | 2.96M | 6.54M |
| EPS Basic | 0.00 | -0.02 | -0.02 | -0.06 | -0.06 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.04 | -0.04 |
| EPS Diluted | 0.00 | -0.02 | -0.02 | -0.06 | -0.06 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 383.27M | 380.45M | 380.36M | 379.43M | 376.33M |
| Average Diluted Shares Outstanding | 390.67M | 380.45M | 380.36M | 379.43M | 376.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |